[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention Group 1 receives Tocilizumab\u200e Vial, a humanized antibody, and an interleukin 6 receptor. A dose of 162mg/0.9ml will be administered once a week Subconsciously for two weeks. Currently, no specific manufacturer has been chosen yet.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - DrugsIntervention Group 2 receives Interferon gamma Vial, a humanized antibody, and an interleukin 12 receptor. A dose of 5mg/200mcg, subcutaneous, every alter day, and Vitamin C a dose of 500mg every 8h will be administered for one week. Currently, no specific manufacturer has been chosen yet.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO DiagnosisControl group: : Only routine medications", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 673, "treatment_name": "Interferon gamma", "treatment_type": "Interferons", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 1299, "treatment_name": "Tocilizumab", "treatment_type": "Interleukin inhibitors", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]